StonvexLoading…
StonvexStonvexStonvexCore line items from KRMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $471.50M | $345.25M | $280.70M | $226.31M |
Operating Income | $72.94M | $63.56M | $48.49M | $20.43M |
Net Income | $17.37M | $12.70M | $4.36M | $-14.10M |
EPS (Diluted) | $0.13 | $0.08 | $0.03 | $-0.09 |
Total Assets | $1.10B | $773.96M | $710.83M | Not available |
Total Liabilities | $721.40M | $577.96M | $528.37M | Not available |
Cash & Equivalents | $33.96M | $11.53M | $5.45M | Not available |
Free Cash Flow OCF − CapEx | $-42.45M | $11.39M | $3.55M | $-27.16M |
Shares Outstanding | 132.32M | 0 | 166.78M | 159.11M |